Weimai
PrivateLast Round
Series E
Oct 1, 2025
Est. Valuation
$708M
Total Funding Raised
$232.76M
Company Overview
Weimai operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series E round in October 2025.
Weimai is a digital healthcare solutions provider that offers an integrated platform for full-cycle disease management, connecting patients with public healthcare institutions and doctors through AI-driven services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Medical AI, EHR & EMR, Workflow Automation
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Weimai Comparables
Compare Weimai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medlinker | 80% | |
| WeDoctor | 79% | |
| Miaoshou Doctor | 73% |
For institutional investors. Book with your work email.
Weimai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 1, 2025 | ||||
| Series D | Jan 7, 2025 | ||||
| Series C Extension | Dec 14, 2020 | ||||
| Early Funding | May 1, 2020 | ||||
| Series C | Jun 20, 2019 | ||||
Series B | Sep 13, 2018 |
For institutional investors. Book with your work email.
Weimai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series D |
| IDG Capital | Series C Extension, Series C |
| Omega Funds | Series C |
| Yuanjing Capital | Series B, Angel, Series D, Series A, Series C, Series C Extension |
| Cenova Capital | Series D, Series C, Series C Extension, Series B |
| Baidu Capital | Series C Extension |
| MPC | Series B, Series C, Series A Extension, Series C Extension, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 224% MoM, reaching 31.3K.
- Oct 1, 2025
Raised $8M in Series E funding.
For institutional investors. Book with your work email.
Weimai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Weimai's valuation, stock price, and market status.
Is Weimai a public or private company?
Weimai is a private company.
What is the current stock price of Weimai?
Weimai is a private company, so its shares have no public market price. Caplight tracks Weimai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Weimai worth (valuation)?
Weimai's valuation is estimated at $708.0M based on funding round data.
Can I buy Weimai stock?
Weimai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Weimai's last funding round?
Weimai's most recent funding round was Series E on October 1, 2025.
Who are the main investors in Weimai?
Key investors in Weimai include IDG Capital, Cenova Capital, Baidu Capital, MPC.
Will Weimai IPO soon?
No public IPO plans have been announced for Weimai.
How can I track Weimai secondary market activity?
Caplight tracks bids, offers, and trades in Weimai's shares on secondary markets.